|
1
|
Ellis GL and Auclair PL: Tumors of the
salivary glands. 3rd edition. Armed Forces Institute of Pathology;
Washington: 1996
|
|
2
|
Teymoortash A: Head and neck: Salivary
gland: Warthin’s Tumors. Atlas Genet Cytogenet Oncol Haematol.
April;2008.http://AtlasGeneticsOncology.org
|
|
3
|
Thangarajah T, Reddy VM,
Castellanos-Arango F and Panarese A: Current controversies in the
management of Warthin tumour. Postgrad Med J. 85:3–8. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yu GY, Liu XB, Li ZL and Peng X: Smoking
and the development of Warthin’s tumour of the parotid gland. Br J
Oral Maxillofac Surg. 36:183–185. 1998.
|
|
5
|
Mark J, Dahlenfors T, Stenman G and
Nordquist A: A human adenolymphoma showing the chromosomal
aberrations del(7)(p12;p14–15) and t(11;19)(q21;p12–13). Anticancer
Res. 9:1565–1566. 1989.PubMed/NCBI
|
|
6
|
Mark J, Dahlenfors R, Stenman G and
Nordquist A: Chromosomal patterns in Warthin’s tumor. A second type
of human benign salivary gland neoplasm. Cancer Genet Cytogenet.
46:35–39. 1990.
|
|
7
|
Mark HF, Hanna I and Gnepp DR: Cytogenetic
analysis of salivary gland type tumors. Oral Surg Oral Med Oral
Pathol Oral Radiol Endod. 82:187–192. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Martins C, Fonseca I, Roque L and Soares
J: Cytogenetic characterisation of Warthin’s tumour. Oral Oncol.
33:344–347. 1997.
|
|
9
|
Bullerdiek J, Haubrich J, Meyer K and
Bartnitzke S: Translocation t(11;19)(q21;p13.1) as the sole
chromosome abnormality in a cystadenolymphoma (Warthin’s tumor) of
the parotid gland. Cancer Genet Cytogenet. 35:129–132. 1988.
|
|
10
|
Nordkvist A, Mark J, Dahlenfors R, Bende M
and Stenman G: Cytogenetic observations in 13 cystadenolymphomas
(Warthin’s tumours). Cancer Genet Cytogenet. 76:129–135. 1994.
|
|
11
|
Enlund F, Behboudi A, Andrén Y, Oberg C,
Lendahl U, Mark J and Stenman G: Altered Notch signaling resulting
from expression of a WAMTP1-MAML2 gene fusion in
mucoepidermoid carcinomas and benign Warthin’s tumors. Exp Cell
Res. 292:21–28. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tirado Y, Williams MD, Hanna EY, Kaye FJ,
Batsakis JG and El-Naggar AK: CRTC1/MAML2 fusion transcript
in high grade mucoepidermoid carcinomas of salivary and thyroid
glands and Warthin’s tumors: implications for histogenesis and
biologic behavior. Genes Chromosomes Cancer. 46:708–715. 2007.
View Article : Google Scholar
|
|
13
|
Fehr A, Roser K, Belge G, Loening T and
Bullerdiek J: A closer look at Warthin tumors with respect to the
t(11;19). Cancer Genet Cytogenet. 180:135–139. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tonon G, Modi S, Wu L, Kubo A, Coxon AB,
Komiya T, O’Neil K, Stover K, El-Naggar A, Griffin JD, Kirsch IR
and Kaye FJ: t(11;19)(q21;p13) translocation in mucoepidermoid
carcinoma creates a novel fusion product that disrupts a Notch
signaling pathway. Nat Genet. 33:208–213. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bell D, Luna MA, Weber RS, Kaye FJ and
El-Naggar AK: CRTC1/MAML2 fusion transcript in Warthin’s tumor and
mucoepidermoid carcinoma: evidence for a common genetic
association. Genes Chromosomes Cancer. 47:309–314. 2008.
|
|
16
|
Ogawa Y, Hong S, Toyosawa S, Chang CK and
Yagi T: Expression of major histocompatibility complex class II
antigens and interleukin-I by epithelial cells of Warthin’s tumor.
Cancer. 66:2111–2117. 1990.PubMed/NCBI
|
|
17
|
Giefing M, Wierzbicka M, Rydzanicz M,
Cegla R, Kujawski M and Szyfter K: Chromosomal gains and losses
indicate oncogene and tumor suppressor gene candidates in salivary
gland tumors. Neoplasma. 55:55–60. 2008.PubMed/NCBI
|
|
18
|
Karhu R, Kähkönen M, Kuukasjärvi T,
Pennanen S, Tirkkonen M and Kallioniemi O: Quality control of CGH:
impact of metaphase chromosomes and the dynamic range of
hybridization. Cytometry. 28:198–205. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Evdokiou A, Webb GC, Peters GB, Dobrovic
A, O’Keefe DS, Forbes IJ and Cowled PA: Localization of the human
growth arrest-specific gene (GAS1) to chromosome bands
9q21.3–q22, a region frequently deleted in myeloid malignancies.
Genomics. 18:731–733. 1993.PubMed/NCBI
|
|
20
|
Orlova KA and Crino PB: The tuberous
sclerosis complex. Ann NY Acad Sci. 1184:87–105. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lininger RA, Park WS, Man YG, Pham T,
MacGrogan G, Zhuang Z and Tavassoli FA: LOH at 16p13 is a novel
chromosomal alteration detected in benign and malignant
microdissected papillary neoplasms of the breast. Hum Pathol.
29:1113–1118. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kadota M, Tamaki Y, Sakita I, Komoike Y,
Miyazaki M, Ooka M, Masuda N, Fujiwara Y, Ohnishi T, Tomita N,
Sekimoto M, Ohue M, Ikeda T, Kobayashi T, Horii A and Monden M:
Identification of a 7-cM region of frequent allelic loss on
chromosome band 16p13.3 that is specifically associated with
anaplastic thyroid carcinoma. Oncol Rep. 7:529–533. 2000.PubMed/NCBI
|
|
23
|
Alcock HE, Stephenson TJ, Royds JA and
Hammond DW: Analysis of colorectal tumor progression by
microdissection and comparative genomic hybridization. Genes
Chromosomes Cancer. 37:369–380. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Summy JM and Gallick GE: Src family
kinases in tumor progression and metastasis. Cancer Metastasis Rev.
22:337–358. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sandros J, Stenman G and Mark J:
Cytogenetic and molecular observations in human and experimental
salivary gland tumors. Cancer Genet Cytogenet. 44:153–167. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Jin Y, Mertens F, Limon J, Mandahl N,
Wennerberg J, Dictor M, Heim S and Mitelman F: Characteristic
karyotypic features in lacrimal and salivary gland carcinomas. Br J
Cancer. 7:42–47. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Persson M, Andrén Y, Moskaluk CA, Frierson
HF Jr, Cooke SL, Futreal PA, Kling T, Nelander S, Nordkvist A,
Persson F and Stenman G: Clinically significant copy number
alterations and complex rearrangements of MYB and NFIB in head and
neck adenoid cystic carcinoma. Genes Chromosomes Cancer.
51:805–817. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Jee KJ, Persson M, Heikinheimo K,
Passador-Santos F, Aro K, Knuutila S, Odell EW, Mäkitie A, Sundelin
K, Stenman G and Leivo I: Genomic profiles and CRTC1-MAML2 fusion
distinguish different subtypes of mucoepidermoid carcinoma. Mod
Pathol. 26:213–222. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Mitelman F, Johansson B and Mertens F:
Mitelman Database of Chromosome Aberrations and Gene Fusions in
Cancer. http://cgap.nci.nih.gov/Chromosomes/Mitelman.
2012
|
|
30
|
Cybulski C, Wokołorczyk D, Huzarski T,
Byrski T, Gronwald J, Górski B, Debniak T, Masojć B, Jakubowska A,
Gliniewicz B, Sikorski A, Stawicka M, Godlewski D, Kwias Z, Antczak
A, Krajka K, Lauer W, Sosnowski M, Sikorska-Radek P, Bar K, Klijer
R, Zdrojowy R, Małkiewicz B, Borkowski A, Borkowski T, Szwiec M,
Narod SA and Lubiński J: A large germline deletion in the Chek2
kinase gene is associated with an increased risk of prostate
cancer. J Med Genet. 43:863–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wild A, Ramaswamy A, Langer P, Celik I,
Fendrich V, Chaloupka B, Simon B and Bartsch DK: Frequent
methylation-associated silencing of the tissue inhibitor of
metalloproteinase-3 gene in pancreatic endocrine tumors. J Clin
Endocrinol Metab. 88:1367–1373. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Romashkova JA and Makarov SS: NF-κB is a
target of AKT in anti-apoptotic PDGF signalling. Nature. 401:86–90.
1999.
|
|
33
|
Verdorfer I, Fehr A, Bullerdiek J, Scholz
N, Brunner A, Krugmann J, Hager M, Haufe H, Mikuz G and Scholtz A:
Chromosomal imbalances, 11q21 rearrangement and MECT1-MAML2 fusion
transcript in mucoepidermoid carcinomas of the salivary gland.
Oncol Rep. 22:305–311. 2009.PubMed/NCBI
|
|
34
|
Kim HJ, Yoo YS, Park K, Kwon JE, Kim JY
and Monzon FA: Genomic aberrations in salivary duct carcinoma
arising in Warthin tumor of parotid gland: DNA microarray and HER2
fluorescence in situ hybridization. Arch Pathol Lab Med.
135:1088–1091. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Gebhart E: Comparative genomic
hybridization (CGH): ten years of substantial progress in human
solid tumor molecular cytogenetics. Cytogenet Genome Res.
104:352–358. 2004.PubMed/NCBI
|
